共 50 条
Characterization of the antinociceptive effect of PhTx3-4, a toxin from Phoneutria nigriventer, in models of thermal, chemical and incisional pain in mice
被引:22
作者:
da Silva, Juliana Figueira
[1
]
Castro-Junior, Celio Jose
[1
]
Oliveira, Sara Marchesan
[2
]
Dalmolin, Gerusa Duarte
[3
]
Silva, Cassia Regina
[4
]
Vieira, Luciene Bruno
[5
]
Diniz, Danuza Montijo
[1
]
Cordeiro, Marta do Nascimento
[6
]
Ferreira, Juliano
[3
]
Souza, Alessandra Hubner
[7
]
Gomez, Marcus Vinicius
[1
]
机构:
[1] Inst Educ & Res, Dept Neurotransmitters, BR-30150240 Belo Horizonte, MG, Brazil
[2] Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97105900 Santa Maria, RS, Brazil
[3] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-80040900 Florianopolis, SC, Brazil
[4] Univ Sao Paulo, Fac Med, BR-14049900 Sao Paulo, Brazil
[5] Univ Fed Minas Gerais, Dept Pharmacol, BR-30170901 Belo Horizonte, MG, Brazil
[6] Ezequiel Dias Fdn, Dept Biochem, BR-30510010 Belo Horizonte, MG, Brazil
[7] Univ Luterana Brasil, BR-92425900 Porto Alegre, RS, Brazil
来源:
关键词:
PhTx3-4;
Anti-Nociceptive;
Mice;
Side-effects;
NMDA receptors;
Intrathecal;
OMEGA-CONOTOXIN MVIIA;
ACTIVATED CALCIUM-CHANNELS;
ARMED SPIDER VENOM;
NEUROPATHIC PAIN;
FORMALIN TEST;
ION CHANNELS;
N-TYPE;
PH-ALPHA-1-BETA TOXIN;
CA2+ CHANNELS;
DORSAL-HORN;
D O I:
10.1016/j.toxicon.2015.09.043
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Venom-derived peptides constitute a unique source of drug prototypes for the pain management. Many of them can modulate voltage-gated calcium channels that are central in the processing of pain sensation. PhTx3-4 is a peptide isolated from Phoneutria nigriventer venom, which blocks high voltage-activated calcium channels with low specificity, thereby leading to neuroprotection in models of ischemia in vitro. The aim of the present work was evaluating the potential of intrathecal PhTx3-4 in the reversal of different nociceptive states in mice, furthermore assessing the potential of PhTx3-4 in triggering motor side effects. We found that bellow 100 pmol/site, PhTx3-4 did not cause major motor side effects. By comparison, omega-conotoxin MVIIA and omega-conotoxin MVIIC triggered motor side effects at the doses of 10 and 100 pmol/site, respectively. Also, PhTx3-4 (30 pmol/site) caused no significant alterations in the forced locomotor activity test (rotarod) and in the exploratory activity test (versamax). In a model of inflammatory persistent pain (formalin test), PhTx3-4 reversed nociceptive behavior both pre or post-administered, although this effect was observed only at the inflammatory phase of the test and not at the neurogenic phase. Comparatively, w-conotoxin MVIIC was effective only when post-administered in the formalin test. Nonetheless, PhTx3-4 treatment was devoid of action in acute nociceptive thermal model (hotplate test), whereas morphine showed efficacy in this test. Efficacy of PhTx3-4 in the formalin test was associated with inhibition of formalin-induced glutamate release in the cerebrospinal fluid. PhTx3-4, but not w-conotoxin MVIIC, reversed NMDA-induced nociceptive behavior indicating a putative role of PhTx3-4 at ionotropic glutamate receptors. Finally, we observed efficacy of PhTx3-4 in ameliorating mechanical hypersensitivity induced by paw incision, a post-operative and more clinically relevant pain model. Taken together, our data show that PhTx3-4 possesses antinociceptive effect in different models of pain in mice, suggesting that this toxin may serve as drug prototype for pain control. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文